🎁 Black Friday: up to 50% off of annual plans
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.66
-0.50 (-3.53%)
At close: Nov 20, 2026, 4:00 PM EST
13.70
+0.04 (0.29%)
After-hours: Nov 20, 2026, 7:30 PM EST

Mineralys Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
96.9438.623.8214.35.232.42
Research & Development
292.81132.01168.5870.3626.2516.31
Operating Expenses
389.75170.6192.484.6631.4818.73
Operating Income
-389.75-170.6-192.4-84.66-31.48-18.73
Interest Expense
-4.02-----0.03
Interest & Investment Income
23.815.9514.5912.761.68-
Other Non Operating Income (Expenses)
--0.01000
EBT Excluding Unusual Items
-369.97-154.65-177.81-71.9-29.8-18.75
Other Unusual Items
------0.66
Pretax Income
-369.97-154.65-177.81-71.9-29.8-19.41
Net Income
-369.97-154.65-177.81-71.9-29.8-19.41
Net Income to Common
-369.97-154.65-177.81-71.9-29.8-19.41
Net Income Growth
------
Shares Outstanding (Basic)
8468493655
Shares Outstanding (Diluted)
8468493655
Shares Change
41.14%39.38%34.13%600.33%3.67%7.64%
EPS (Basic)
-4.38-2.29-3.66-1.99-5.77-3.89
EPS (Diluted)
-4.38-2.29-3.66-1.99-5.77-3.89
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-153.03-142.43-166.41-81.17-29.22-14.56
Free Cash Flow Per Share
-1.81-2.10-3.43-2.24-5.66-2.92
EBITDA
-389.72-170.55-192.36---
D&A For EBITDA
0.030.060.04---
EBIT
-389.75-170.6-192.4-84.66-31.48-18.73
SEC Filings: 10-K · 10-Q